SCHEMBL24257837

SCHEMBL24257837

CCCCCc1ccc(CCOc2ccc(S(=O)(=O)Nc3ncc(C(=O)O)cn3)cc2)cc1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ TP53 P04637 2/20 0.48
▸ MAPT P10636 1/20 0.48
▸ SMN1; SMN2 Q16637 3/20 0.48
▸ LMNA P02545 1/20 0.48
▸ TSHR P16473 2/20 0.47
▸ CYP1A2 P05177 1/20 0.47
▸ CYP3A4 P08684 1/20 0.47
▸ CYP2D6 P10635 1/20 0.47
▸ CYP2C9 P11712 1/20 0.47
▸ CYP2C19 P33261 1/20 0.47
▸ HTT P42858 1/20 0.47
▸ AKT1 P31749 2/20 0.47
▸ IRS1 P35568 2/20 0.47
▸ GAB1 Q13480 2/20 0.47
▸ KDM4E B2RXH2 1/20 0.47
▸ TDP1 Q9NUW8 1/20 0.47
▸ NPC1 O15118 1/20 0.46
▸ RXFP1 Q9HBX9 1/20 0.46
▸ PLA2G4A P47712 1/20 0.46
▸ PLA2G4B P0C869 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22079909 0.92 AKT1 (0.48) AKT1IRS1GAB1KDM4ETDP1
SCHEMBL22080431 0.91 KDM4E (0.54) MAPTSMN1; SMN2LMNAHTTAKT1
SCHEMBL31682088 0.85 MCL1 (0.40) TDP1PLA2G4BMCL1BCL2A1
SCHEMBL22080432 0.81 TDP1 (0.61) TP53SMN1; SMN2LMNATSHRTDP1
SCHEMBL22080190 0.81 KDM4E (0.49) SMN1; SMN2AKT1IRS1GAB1KDM4E
SCHEMBL24257838 0.81 TDP1 (0.68) MAPTSMN1; SMN2LMNAHTTKDM4E
SCHEMBL24257905 0.81 NPC1 (0.42) TP53MAPTSMN1; SMN2LMNATSHR
SCHEMBL3551452 0.80 SMN1; SMN2 (0.63) TP53MAPTSMN1; SMN2LMNATSHR
SCHEMBL22079879 0.79 KDM4E (0.57) MAPTSMN1; SMN2AKT1IRS1GAB1
SCHEMBL3554413 0.79 SMN1; SMN2 (0.65) TP53MAPTSMN1; SMN2LMNATSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220048968-A1 INSULIN CONJUGATES SANOFI (FR) 2022-02-17 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220048968-A1 INSULIN CONJUGATES IAPP, INSR, IGF1R TP53 314/4885MAPT 3611/4885SMN1; SMN2 1332/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback